Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
出版年份 2014 全文链接
标题
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
作者
关键词
Breast cancer, Tumor progression, Cholesterol biosynthesis inhibitors, Estrogen receptor
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 146, Issue 1, Pages 51-62
出版商
Springer Nature
发表日期
2014-05-30
DOI
10.1007/s10549-014-2996-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
- (2013) Marcelo Madeira et al. BMC CANCER
- Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase
- (2013) Wei-Lan Yeh et al. PLoS One
- 27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology
- (2013) E. R. Nelson et al. SCIENCE
- 27-Hydroxycholesterol Promotes Cell-Autonomous, ER-Positive Breast Cancer Growth
- (2013) Qian Wu et al. Cell Reports
- Cytotoxic Effects of Combination of Oxidosqualene Cyclase Inhibitors with Atorvastatin in Human Cancer Cells
- (2012) Davide Staedler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Estrogen receptor prevents p53-dependent apoptosis in breast cancer
- (2012) S. T. Bailey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
- (2011) Suzanne E. Wardell et al. BIOCHEMICAL PHARMACOLOGY
- Apigenin Prevents Development of Medroxyprogesterone Acetate-Accelerated 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Sprague-Dawley Rats
- (2011) B. Mafuvadze et al. Cancer Prevention Research
- An inverse docking approach for identifying new potential anti-cancer targets
- (2011) Sam Z. Grinter et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- The role of estrogen receptor β (ERβ) in malignant diseases—A new potential target for antiproliferative drugs in prevention and treatment of cancer
- (2010) Margaret Warner et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
- (2010) Yayun Liang et al. BREAST CANCER RESEARCH AND TREATMENT
- Minireview: Estrogen Receptor-β: Mechanistic Insights from Recent Studies
- (2010) Bonnie J. Deroo et al. MOLECULAR ENDOCRINOLOGY
- Epidermal growth factor receptor cross-talks with ligand-occupied estrogen receptor-α to modulate both lactotroph proliferation and prolactin gene expression
- (2009) Shenglin Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells
- (2009) Oliver Treeck et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis
- (2008) Harald Seeger et al. GYNECOLOGICAL ENDOCRINOLOGY
- Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
- (2008) Ana Maria Sotoca Covaleda et al. TOXICOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search